MedTrace Logo

The Neu-Prem Trial: Neuromonitoring of Preterm Newborn Brain During Birth Resuscitation

NCT02605733 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2021-12-13

No results posted yet for this study

Summary

The purpose of this study is to characterize the normal brain function of premature infants (23 to 31+6 weeks GA) during birth transition and through the first 72 hours of life.

Conditions

  • Neurologic Manifestations
  • Premature Birth
  • Hypoxia-Ischemia, Brain

Interventions

DEVICE

EEG

amplitude integrated electroencephalography

DEVICE

NIRS

regional tissue oximetry

Sponsors & Collaborators

  • The Gerber Foundation

    collaborator OTHER

  • Sharp HealthCare

    lead OTHER

Principal Investigators

  • Anup Katheria, MD · Sharp HealthCare

Eligibility

Max Age
72 Hours
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-12-31
Completion
2021-05-13

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02605733 on ClinicalTrials.gov